Dr. Waugh's Lab Logo MCL Home David S. Waugh National Cancer Institute Home Page Dr. Waugh's Home Page Dr. Waugh's Research Summary Dr. Waugh's Publications Dr. Waugh's Staff Dr. Waugh's Structure Gallery Dr. Waugh's Technical Information
 
pRK1037
 
 Description: This TVMV protease expression vector is intended to be used for controlled intracellular processing of fusion proteins (TVMV protease substrates) in E. coli.
   
 Origin: A pZ derivative (Lutz and Bujard, 1997)
   
 Replicon: p15A
   
 Antibotic Resistance: Kanamycin
   
 Promotor: Synthetic λPL/tetO
   
 Inducer: anhydrotetracycline (100 µg/liter)
   
 Notes: Expression of the TVMV protease gene on pRK1037 will be constitutive unless the host strain produces Tet repressor. Regulated expression can be achieved in DH5alphaPro™ or BL21Pro™ cells (Clontech). The specificity of TVMV protease is distinct from that of TEV protease. The canonical recognition site for TVMV protease is ETVRFQS, with cleavage occurring between Q and S. The TVMV protease open reading frame on pRK1037 was constructed from synthetic oligonucleotides and has been codon-optimized for expression in E. coli. For best results, perform intracellular processing experiments at 30 °C.
   
 Literature Citations: Lutz, R. and Bujard, H. (1997). Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucl. Acids Res. 25: 1203-10; Yoon, H. Y., Hwang, D. C., Choi, K. Y., and Song, B. D. (2000). Proteolytic processing of oligopeptides containing the target sequences by the recombinant tobacco vein mottling virus NIa protease. Mol. Cells 10: 213-219.
   
 Nucleotide Sequence:  
   
   
MCL Bottom Navigation Bar MCL Home MCL Web Site Map MCL Contact Information MCL Web Disclaimer NCI-FCRDC Web Site NCI-CCR Web Site